|
AUGENHEILKUNDE
213/1999 ISSUE
1
Abstracts:
-
Risk factors for trabeculectomy failure Tobias LF Koller,
Jörg Stürmer, Balder Gloor
-
Long-term results of conjunctiva-limbus autografts in patients
with pterygia Petra Pulte, Arnd Heiligenhaus, Jörg Koch, Klaus-Peter
Steuhl, Theo Waubke
-
Botulinum toxin A-induced protective ptosis in indolent corneal
ulcers or erosions Gabriele-Charlotte Gusek-Schneider, Frank Erbguth
-
Characteristics of RPE-Autofluorescence in Different Lesions
of the Late Age-related Macular Degeneration Georg Spital, Martin
Radermacher, Christian Müller, Gabriele Brumm, Albrecht Lommatzsch,
Daniel Pauleikhoff
-
Dynamics of the changes of lipofuscin distribution in the
retinal pigment epithelium in age-related macular degeneration Andrea
von Rückmann, Karl-Georg Schmidt, Fredrick W Fitzke, Alan C Bird, Karl
Wilhelm Jacobi
-
Keratocytes density in the in vivo cornea. Automatic
quantification with a modified confocal microscope MICROPHTHAL Joachim
Stave, Christine Slowik, Susanne Somodi, Christian Hahnel, Gerald Grümmer,
Rudolf Guthoff
-
The Holzwig Irisretractor and its use in cases of narrow
pupils Detlef H Holzwig
-
Topical application of Metronidazole gel as an effective
alternative treatment for chronic Demodex blepharitis - a case report
Anna K Junk, Andreas Lukacs, Anselm Kampik
-
Choroidal infiltration in myelodysplastic syndrome
Faramarz Madjlessi, Katharina Dann, Christoph Althaus, Rainer Sundmacher,
Guido Meckenstock
-
Prevention of amblyopia in children with sudden-onset eyelid
closure - A new method of keeping the visual axis open by insertion of a
scleral immersion shell Joachim Esser
-
Ophthalmomyiasis externa caused by oestrus ovis in Franconia
Michael JM Groh, Anselm Jünemann, Rudolf Zilch
-
Latanoprost induced macular edema Alexander Reis, Christoph
Althaus, Rainer Sundmacher
S. 01-08 (Art. 366)
Risk factors for trabeculectomy
failure
Tobias LF Koller, Jörg Stürmer, Balder Gloor
Background Trabeculectomy is today the filtering procedure of choice,
because complications are rare and success-rates high. A modification of
our technique (fornix-based conjunctival flap closed by a running suture)
introduced 3 years ago, has lead us to this retrospective assessment of
complications and success-rates. Some of the risk factors for failure are
known, others however remain obscure. This retrospective series was also
used to further identify some of these risk factors for trabeculectomy
failure.
Patients and Methods All 388 trabeculectomies performed between January
1992 and June 1994 at our hospital were included in the study. Important
pre- and postoperative data were retrospectively assessed from patients case
notes, with a special interest in the course of post-operative intra-ocular
pressure (IOP). Two major groups were differentiated: Those with open-angle
glaucoma (OAG) (i.e. primary open-angle glaucoma (POAG), pseudoexfoliation
glaucoma (PEX) and pigment dispersion syndrome(PDS)), and other various glaucoma
diagnoses. Risk factors were assessed using Cox-proportional hazard model
adopting three different criteria for success.
Results The best success-rate after 12 months of follow-up had patients
with narrow angle glaucoma (93.1%)(at least those suitable for filtering
surgery), followed by patients with POAG (92.8%), 2° open-angle glaucoma
(81.8%), aphakic (75%), juvenile (70.6%) and PDS (52.9%). Pseudophakia and
development of an encapsulated bleb (Tenon' cyst) were identified as significant
(p < 0.05) risk factors for failure. In addition, YAG-Laser Iridotomy
in OAG-group and Aphakia in the group of various glaucoma diagnoses were
identified as risk factors for successful post-operative IOP control.
Conclusions Filtering surgery (trabeculectomy) is a potent method
to reduce IOP. Pseudophakia and an encapsulated bleb are the main risk factors
for surgical failure. Because of amazingly high success-rates we tend to
perform filtering surgery today earlier than ten years ago, especially as
previous long-term topical antiglaucoma treatment may reduce filtering surgery
success.
Key words glaucoma - trabeculectomy - encapsulated bleb - glaucoma
diagnoses - topical antiglaucoma treatment - Argon-Laser trabeculoplasty
- pseudophakia-aphakia - cyclocryocoagulation
[ back ]
S. 09-14 (Art. 371)
Long-term results of conjunctiva-limbus
autografts in patients with pterygia
Petra Pulte, Arnd Heiligenhaus, Jörg Koch, Klaus-Peter
Steuhl, Theo Waubke
Background Conjunctiva-limbus autografting is known as a safe surgical
technique for the removal of pterygia, with a low rate of recurrence. However,
the long-term effect of this surgical maneuver is not clear. This study now
investigates the long-term efficacy of conjunctiva-limbus autografts to prevent
pterygium recurrence.
Methods Conjunctiva-limbus transplants for primary (n=62) or recurrent
(n=8) pterygia were reevaluated 11 to 83 months after surgery (mean: 44.97
months). Slit-lamp appearance and photomicrographs were studied with respect
to the configuration of the transplant and the recurrence of the fibrovascular
tissue typical of pterygia.
Results Corneal pterygium recurrence has been observed in 2 cases.
Fibrovascular tissue was found at the peripheral transplant-margin in 15
cases, and transplant compression towards the limbal margins were detected
in further 7 patients. These conjunctival changes have not been observed
during the first postoperative months.
Conclusions Conjunctiva-limbus autografts in pterygia have excellent
efficacy against recurrence within the first few years. The transplant
compression and fibrovascular changes within the peripheral conjunctiva seen
in this study suggest that recurrencies might, however, develop on the
long-term.
Key words pterygium - conjunctiva - cornea - conjunctival autograft
[ back ]
S. 15-22 (Art. 368)
Botulinum toxin A-induced protective
ptosis in indolent corneal ulcers or erosions
Gabriele-Charlotte Gusek-Schneider, Frank Erbguth
Background Botulinumtoxin A has been introduced as a local injection
therapy of different conditions with focal muscular hypercontractions. In
the ophthalmologic field the toxin has proven its efficacy in the therapy
of blepharospasm and hemifacial spasm. There are only few reports on the
use of a botulinum toxin A to induce a protective ptosis in patients with
persistent corneal ulcers.
Patients and methods 21 patients who failed to respond to conservative
therapy of corneal erosions or ulcers of different origin received a botulinum
toxin A injection into the levator palpebrae superioris muscle.
Results The ptosis began after a mean of 1.5 days (1-3 days) and was
complete after a mean of 5.1 days (3-12 days) after injection. Complete recovery
of the levator function could be observed after a mean of 12.4 weeks (4-24
weeks). In 13 patients (61,8%) the botulinum toxin A induced protective ptosis
lead to a complete healing of indolent ulcers or erosions, in 4 patients
(19%) an additional tarsorrhaphy was necessary. In 3 patients no healing
could be observed during follow up, in one patient (with neuroparalytic ulcer)
the injection was given prophylactically. The period of healing on average
was 3,8 weeks. There was no relationship between the healing rate and the
duration of the corneal disease prior to the botulinum toxin injection. The
mean healing rate of younger patients was higher (75%) than that of older
patients (53.8%) and higher in erosions (70%) than in ulcers (30%). No side
effects were observed besides in one patient the undesirable duration of
the ptosis of a half year.
Conclusion The induction of a protective ptosis with botulinum toxin
A injection is an efficacious treatment alternative in persistent corneal
erosions and ulcers before performing a tarsorrhaphy. This method is preferrable
especially in patients with lagophthalmos due to facial nerve paresis with
potential recovery.
Key words botulinum toxin A- corneal ulcers- corneal disease- protective
ptosis
[ back ]
S. 23-31 (Art. 355)
Characteristics of RPE-Autofluorescence
in Different Lesions of the Late Age-related Macular
Degeneration
Georg Spital, Martin Radermacher, Christian Müller,
Gabriele Brumm, Albrecht Lommatzsch, Daniel Pauleikhoff
Background Lipofuscin is the main fluorophore of the human fundus.
Because lipofuscin is the result of the accumulation of metabolic debris
in pigmentepithelial cells (RPE), the autofluorescence can be interpreted
as a clinical sign for the metabolic activity of the RPE. In order to get
informations of RPE-function in different types of late AMD, the autofluorescence
patterns in patients with late AMD were analyzed.
Material and method A prospective examination of the
fundus-autofluorescence of 64 eyes of 52 patients with different types of
late AMD was performed using a confocal scanning-laser-opthalmopscope. The
autofluorescence images were categorized in respect to the type of late AMD
according to the opthalmoscopic and fluoresceine-angiographic findings.
Results Reduced autofluorescence was found in the centre of occult
(78.6%) and classic (100%) choroidal neovascularisations (NV) as well as
in the occult NV of RPE detachments. A loss of autofluorescence was related
to the RPE free area of RPE-tears (100%) and to RPE-atrophy (88.9%) with
sometimes increased autofluorescence at the rim. Increased autofluorescence
could be seen at the surface of RPE-detachments (71.4%), in the area of the
shrink age of RPE in RPE-tears (100%) as well as at RPE-proliferations in
small occult NV (100%). Disciforme scars showed variable patterns of
autofluorescence.
Conclusion The autofluorescence of the RPE can be analyzed clinically
with the described method. Different patterns of autofluorescence could be
revealed in different types of late AMD. Increased autofluorescence was found
in lesions with proliferative or phagocytotic metabolic activity of the RPE
like RPE-detachments, shrinked RPE in RPE-tears or occult NV with
RPE-proliferations. The reduced autofluorescence in occult or classical choroidal
NV can be interpreted as a sign of decompensation of the RPE and was also
seen in areas with RPE-loss.
Key words Age-related macular degeneration - Autofluorescence - Lipofuscin
- retinal pigment epithelium
[ back ]
S. 32-37 (Art. 359)
Dynamics of the changes of lipofuscin
distribution in the retinal pigment epithelium in age-related macular
degeneration
Andrea von Rückmann, Karl-Georg Schmidt, Fredrick W
Fitzke, Alan C Bird, Karl Wilhelm Jacobi
Background It is thought that lipofuscin plays a central role in the
pathogenesis of age-related macular degeneration (AMD). The lack of
histopathological material has been a severe limitation in our knowledge
on lipofuscin in this disease. A new technique has been developed that allows
in vivo imaging of fundus autofluorescence derived from lipofuscin in the
retinal pigment epithelium (RPE) using a confocal Laser Scanning Ophthalmoscope
(LSO). We studied the dynamics of lipofuscin accumulation and degradation
in patients with AMD.
Materials and Methods Serial examinations of the spatial distribution
of fundus autofluorescence were performed in 148 eyes of 74 patients with
AMD using a LSO over a period of 1-3.5 years.
Results Fundus autofluorescence changed over time in almost all eyes
studied. Areas of increased autofluorescence occurred progressively during
follow up in eyes with drusen and hyperpigmentation. The size of pathologic
autofluorescence increased over time in almost all eyes with geographic atrophy,
subretinal neovascularisations and disciform scars. Irregular autofluorescence
was seen over most subretinal neovascularisations. Autofluorescence intensity
decreased in old subretinal neovascularisations and disciform scars over
time.
Conclusions Changes of the distribution of autofluorescence occur
in eyes with AMD over time. Fundus autofluorescence imaging allows in vivo
analysis of the dynamics of accumulation and degradation of lipofuscin in
the RPE in eyes with AMD and documentation of metabolic activity of the
RPE.
Key words lipofuscin - laser scanning ophthalmoscope - age related
macular degeneration - autofluorescence
[ back ]
S. 38-44 (Art. 373)
Keratocytes density in the in vivo cornea.
Automatic quantification with a modified confocal microscope
MICROPHTHAL
Joachim Stave, Christine Slowik, Susanne Somodi, Christian
Hahnel, Gerald Grümmer, Rudolf Guthoff
Background The MICROPHTHAL is a confocal slit light scanning microscope
for a non-invasive in-vivo examination of corneal structures of human eyes.
With this instrument even thin layers of corneal tissue can be imaged in
good quality. Otherwise, blurring of single frames and deviations from the
z-axis in video-sequences caused by high speed movements of the eye would
normally prevent a measurement the density of keratocytes in the cornea.The
goal of the investigation was optical pachymetry, the automatical measurement
of the keratocytes density and a 3D-dimensional reconstruction of the central
cornea in-vivo under constant imaging conditions.
Materials and Methods We developed a low-vacuum suction cup system
for stabilizing the eye in front of the microscope objective during the z-scan
through the cornea. A stepmotor shifting system for the objective locates
inside the suction cup with a central hole was installed underneath
themicroscope. Control of this system via computer facilitated shifting the
focal plane along the z-axis. The layer images were recorded using a S-VHS-tape
and saved on the PC. The digital analysis was performed using a special software
to automatically and off-line evaluate the density of keratocytes in combination
with the 3D-reconstruction. The software also corrected the background
illumination and small axial jitter. After this procedure the keratocytes
density and the 3D-reconstruction in 70 images of the z-scan were calculated.
We examined 47 corneas of 25 healthy probands. The range of age was 25-56
years. Independent control evaluation of the video sequences were taken manually
on an INDIGO HIGH IMPACT workstation.
Results By assign all keratocytes to the corneal measurement volume
we found a averaged density of 15 730 cells/mm3 in the central cornea. The
averaged thicknes of the cornea was 0.556 mm. The control valuation of identical
video-sequences on the workstation accomplished the same result of 16 000
keratocytes/mm3, also similar the result of the automatically measurement
with the modified software.
Conclusions This modification of the microscope is a promising in-vivo
tool for optical pachymetry and quantitative examination of corneal
microstructures. The stabilization effect of the low-vacuum suction cup system
in the front of the microscope for computer-controlled valuation of the density
profile of keratocytes and the 3D-reconstruction of a central corneal volume
element has produced encouraging results. Characterization of pathophysiological
changes in the distribution of keratocytes after excimer laser ablation for
phototherapeutic or photorefractive keratectomy, for example, can be estimated
without pain for the patients.
Key words confocal scanning microcopy - eye movement - suction
stabilization - density of keratocytes - 3D-reconstruction
[ back ]
S. 45-47 (Art. 364)
The Holzwig Irisretractor and its use
in cases of narrow pupils
Detlef H Holzwig
Background The objective was to develop an easy to handle tool for
temporary implantation to dilate narrow pupils.
Material and Methods High molecular PMMA was used to lathe cut a v-shaped
device with sides of 6.9 mm length, 0.8 mm height and 0.4 mm width which
opens 7.0 mm. Positioning holes of 0.5 mm diameter are located in the caudal
ends of the sides. The HIR was used during cataract extraction in 24 patients
with mydriatic-resistent pupils,amblyopia or distinctive macula
degeneration.
Results In all 26 cases cataract extraction was made easier due to
physiologically dilated pupils. The risk of an intraoperative miosis was
effevtively eliminated. In two cases removal was difficult as the lower tunnel
lip interfered with the removal of the HIR.
Conclusion In comparsion with the commercially available devices,
the HIR is the simplest, safest and most physiologic alternative.
Key words irisretractor - miosis - pupildilatator - pupil expander
- cataractoperation
[ back ]
S. 48-50 (Art. 343)
Topical application of Metronidazole
gel as an effective alternative treatment for chronic Demodex blepharitis
- a case report
Anna K Junk, Andreas Lukacs, Anselm Kampik
Background Blepharoconjunctivitis is the commonest manifestation of
ocular rosacea. Cilia epilation proves Demodex folliculorum, considered an
etiologic factor in rosacea. Complications and differential diagnosis include
dry eyes, seborrheic, bacterial and allergic blepharoconjunctivitis. Treatment
involves lid scrubs and mercury ointment, its duration is limited to 6 weeks
under frequent control due to corneal toxicity of mercury.
History and signs 30-year-old female with complaint of red, irritated
eyes for 21 years, resistant to antibiotics and antiallergics. General medical
history unremarkable, mercury allergy. Acuity: R/L 20/20. Biomicroscopy:
red, thickened eyelid margins, crusty debris on rarefied, partially broken
lashes, conjunctival telangiectasia, low tear meniscus, furth-er ophthalmologic
examination unremarkable. Diagnosis: chronic Demodex blepharoconjunctivitis.
Therapy and outcome Conventional treatment was contraindicated due
to mercury allergy. Alternative oral minocycline 100 mg daily brought no
subjective nor objective relief. Combination of lid scrubs and 2% Metronidazole
gel relieved symptoms and halved number of mites after 1 month, lashes grew
again after 2 months. Treatment was discontinued after 6 months as Demodex
folliculorum proof remained negative. No relapse occurred during 1 year.
Conclusions Topical Metronidazole 2% proved to be an effective treatment
of chronic Demodex blepharoconjunctivitis in our case and thus may offer
a new and save alternative to existing therapies. Neither ocular nor systemic
side effects occurred. Controversial theories on the aetiology of blepharitis
are discussed.
Key words rosacea - Demodex - chronic - blepharitis -
blepharoconjunctivitis - Metronidazole
[ back ]
S. 51-54 (Art. 375)
Choroidal infiltration in myelodysplastic
syndrome
Faramarz Madjlessi, Katharina Dann, Christoph Althaus, Rainer
Sundmacher, Guido Meckenstock
Background Myelodysplastic syndrome is a clonal disease of the
hematopoetic system characterized by insufficiency of affected bone marrow
cell lines. After long-term course of myelodysplastic syndrome an acceleration
towards acute myeloic leukemia is a frequent finding. Involvement of the
eye is a well known phenomenon in acute leukemia or in blast crisis with
chronic leukemias. Eye involvement in myelodysplastic syndrome showing its
transition into acute myeloic leukemia however has been published in only
few cases.
Case report We present a 70-year-old male patient suffering from
myelodysplastic syndrome, complaining of an acute visual decrease to 0.05
in the left eye. Clinical findings, ultrasound and fluoresceine angiography
were in accordance with choroidal infiltration. From the hematologic findings,
the myelodysplastic syndrome had been in partial remission after chemotherapy
without any sign of relapse or exacerbation. Only because of the ophthalmologic
diagnosis, bone marrow aspiration was performed and revealed progression
of myelodysplastic syndrome to acute myeloic leukemia. Prompt administration
of chemotherapy and external radiation of the posterior pol of the eye led
to complete resolution of the fundus lesion within 10 days and visual acuity
recovered to 0.8.
Conclusion To the best of our knowledge this is the first patient
with a choroidal infiltration as the initial sign of progression of
myelodysplastic syndrome to acute myeloic leukemia. Realizing this possibility
helps for an early diagnosis and rapid therapy which is so crucial in prolonging
life.
Key words Choroidal infiltration - Myelodysplastic syndrome - diagnosis
- therapy
[ back ]
S. 55-59 (Art. 354)
Prevention of amblyopia in children
with sudden-onset eyelid closure - A new method of keeping the visual axis
open by insertion of a scleral immersion shell
Joachim Esser
Background Complete eyelid closure by capillary eyelid hemangioma
or ptosis in the first months of life is an indication for acute measures
to prevent amblyopia. Since it is sometimes not possible to hold up the affected
upper eyelids with adhesive tape (mechanical obstacle, danger of skin maceration
in involvement of the forehead) or not sufficently (intense divergence),
an alternative method will be presented for emergency treatment of blockade
of the optical axis.
Methods The eyelids are kept open mechanically with a cylindrical
tube of perspex (scleral immersion shell), which is normally used for echography
of the anterior segment and for biometry (immersion technique). After surface
anesthesia, it can be readily inserted. Its area of contact to the sclera
has the form of a scleral shell. A drop of lubricant is applied into the
tube at intervals of about five minutes.
Patients and Results In a six-week-old girl with complete eyelid closure
owing to a facial hemangioma, adequate eyelid opening could only be achieved
by insertion of the scleral immersion shell. In an eleven-months-old boy
with complete ptosis and divergence as well as vertical deviation, the optical
axis could only be kept open by insertion of the scleral immersion shell
and by simultaneous displacement to the temporal side (adhesive tape). The
uncomplicated performance for up to two hours daily was initially carried
out in the hospital and later by the parents, and could be terminated after
five and three and a half weeks, respectively, thanks to improvement due
to therapy or spontaneous improvement.
Conclusions Mechanical eyelid opening by insertion of a scleral immersion
shell serves to bridge over the time interval to the onset of spontaneous
improvement or the success of a causal therapy. The advantages consist in
the good handling, also for parents, the low danger of injury and the ubiquitous
and rapid availibility (basic equipment of an ophthalmological ultrasonography
unit).
Key words Deprivation amblyopia - capillary eyelid hemangioma - ptosis
- prevention of amblyopia - emergency case - scleral immersion shell
[ back ]
S. 60-62 (Art. 267)
Ophthalmomyiasis externa caused by oestrus
ovis in Franconia
Michael JM Groh, Anselm Jünemann, Rudolf Zilch
Background Ophthalmological diseases caused by parasites are a very
rare entity in middle europe. Ophthalmomyiasis caused by parasites living
in our country are only reported as case history in literature.
Patient We report on a 28-year old patient, seen in our department
in august 1997 suffering from ophthalmomyiasis externa.
Case history The male patient was riding on a motorbike when a fly
gets into his right eye. 12 hours later he had a feeling of pain in the eye.
When having a closer look to his right eye, he found some fly larva (2.0!0.8
mm) in the conjunctival sack. The patient could extract the fly larva from
the conjunctival sack by himself. On examination at our department we found
a unspecific irritation of the conjunctiva. The fly larva was identified
as larva of oestrus ovis ("Schafsbremse").
Conclusion Although ophthalmomyiasis is a very rare entity in middle
europe single appearance is possible even in our country. No specific therapy
was necessary in this case.
Key words ophthalmomyiasis externa - unspecific conjunctivitis - fly
larva - oestrus ovis
[ back ]
S. 63-64 (Art. 377)
Latanoprost induced macular
edema
Alexander Reis, Christoph Althaus, Rainer Sundmacher
Background Latanoprost represents a new therapeutic option in the
treatment of chronic open angle glaucoma. It has only recently been reported
for the first time that latanoprost caused cystoid macular edema in pseudophakic
patients.
Case report A 60-year-old pseudophakic patient who suffered from a
10-year history of glaucoma, revealed a cystoid macular edema on fluorescence
angiography after 10 days of treatment with latanoprost. One week after cessation
of latanoprost therapy the cystoid edema in fluorescence angiography had
resolved and the vision improved from 0.4 to 0.8.
Conclusions With respect to this severe complication, latanoprost
should be used with great care and in clear indications, particularly in
patients with risk of blood-aqueous leakage e.g. pseudophakic patients.
Key words Glaucoma - medical therapy - side effects
[ back ]
|